In conclusion, in our study, we demonstrate that Musashi protein knockdown downregulates several important stem cell characteristics in breast cancer, including CD44, vimentin and GBX2, likely due to Notch pathway downregulation. This evidence concerns the gene GBX2 and breast cancer.